Knockdown of STAT3 expression in SKOV3 cells by biodegradable siRNA-PLGA/CSO conjugate micelles

Colloids and Surfaces B: Biointerfaces

Volumn 127, Issue , 2015, Pages 155-163

  Zhao, Yunchun ^a   Zheng, Caihong ^b   Zhang, Li ^b   Chen, Yue ^b   Ye, Yiqing ^b   Zhao, Mengdan ^b  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Chitosan oligosaccharide (CSO); Gene knockdown; Micelles; SiRNA PLGA conjugates; STAT3

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; CELL DEATH; CELLS; CHITIN; CHITOSAN; COPOLYMERS; COVALENT BONDS; CYTOLOGY; GENES; GENETIC ENGINEERING; LIPOSOMES; OLIGOSACCHARIDES; PARTICLE SIZE; TRANSCRIPTION;

AQUEOUS ENVIRONMENT; CHITOSAN OLIGOSACCHARIDE; GENE KNOCK DOWN; LOW MOLECULAR WEIGHT; OVARIAN CANCER CELLS; SIRNA-PLGA CONJUGATES; SMALL INTERFERING RNA; STAT3;

MICELLES;

CHITOSAN; DISULFIDE; LIPOFECTAMINE; NITROGEN; OLIGOSACCHARIDE; PHOSPHATE; POLYGLACTIN; SMALL INTERFERING RNA; STAT3 PROTEIN; THIOL; BIOMATERIAL; LACTIC ACID; MICELLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL TRANSPORT; COMPLEX FORMATION; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DISULFIDE BOND; DRUG DOSAGE FORM COMPARISON; DRUG STABILITY; GENE SILENCING; HUMAN; HUMAN CELL; MICELLE; OVARIAN CANCER CELL LINE; PARTICLE SIZE; PROTEIN EXPRESSION; RNA INTERFERENCE; SURFACE CHARGE; ZETA POTENTIAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENETIC TRANSFECTION; METABOLISM; PROTON NUCLEAR MAGNETIC RESONANCE; REAL TIME POLYMERASE CHAIN REACTION; STATIC ELECTRICITY; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BIOCOMPATIBLE MATERIALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHITOSAN; GENE KNOCKDOWN TECHNIQUES; HUMANS; LACTIC ACID; MICELLES; PARTICLE SIZE; POLYGLYCOLIC ACID; PROTON MAGNETIC RESONANCE SPECTROSCOPY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; STATIC ELECTRICITY; TRANSFECTION;

EID: 84922454019     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.01.034     Document Type: Article

References (36)

1. Takahashi Y., Nishikawa M., Takakura Y. Adv. Drug Deliv. Rev. 2009, 61:760.
2. Whitehead K.A., Langer R., Anderson D.G. Nat. Rev. Drug Discov. 2009, 8:129.
3. Tseng Y.C., Mozumdar S., Huang L. Adv. Drug Deliv. Rev. 2009, 61:721.
4. Castanotto D., Rossi J.J. Nature 2009, 457:426.
5. Yang X.Z., Dou S., Sun T.M. J. Controlled Release 2011, 156:203.
6. Kim H.K., Davaa E., Myung C.S. J. S. PARK. Int. J. Pharm. 2010, 392:141.
7. Beyerle A., Braun A., Banerjee A., Ercal N., Eickelberg O., Kissel T.H., Stoeger T. Biomaterials 2011, 32:8694.
8. Lee S.Y., Huh M.S., Lee S., Lee S.J., Chung H., Park J.H., Oh Y.K., Choi K., Kim K., Kwon I.C. J. Controlled Release 2010, 141:339.
9. Katas H., Cevher E., Alpar H.O. Int. J. Pharm. 2009, 144:144.
10. Zheng W., Liu Y., Yu Q., Cao C., Zheng C., Sun D., Ren X., Liu J. Acta Biomater. 2014, 29.
11. Endoh T., Ohtsuki T. Adv. Drug Deliv. Rev. 2009, 61:704.
12. Han S.E., Kang H., Shim G.Y., Suh M.S., Kim S.J., Kim J.S., Oh Y.K. Int. J. Pharm. 2008, 353:260.
13. Ye Y.Q., Yang F.L., Hu F.Q., Du Y.Z., Yuan H., Yu H.Y. Int. J. Pharm. 2008, 352:294.
14. Shim M.S., Kwon Y.J. FEBS J. 2010, 277:4814.
15. Musacchio T., Vaze O., Souza G.D., Torchilin V.P. Bioconjug. Chem. 2010, 21:1530.
16. Li J., Cheng D., Yin T., Chen W., Lin Y., Chen J., Li R., Shuai X. Nanoscale 2014, 6:1732.
17. Liao Z.X., Peng S.F., Chiu Y.L., Hsiao C.W., Liu H.Y., Lim W.H., Lu H.M., Sung H.W. J. Controlled Release 2014, 26:168.
18. Mutisya D., Selvam C., Lunstad B.D., Pallan P.S., Haas A., Leake D., Egli M., Rozners E. Nucl. Acids Res. 2014, 42:6542.
19. Maeda Y., Pittella F., Nomoto T., Takemoto H., Nishiyama N., Miyata K., Kataoka K. Macromol. Rapid Commun. 2014, 35:1211.
20. Kim S.H., Jeong J.H., Lee S.H., Kim S.W., Park T.G. J. Controlled Release 2006, 116:123.
21. Li Q.H., Zhu J.H., Liu L., Yue Y. Chem. Res. Chin. Univ. 2012, 28:856.
22. James E., Darnell J. Science 1997, 277:1630.
23. Shihle M., Davidson B. Future Oncol. 2009, 5:1641.
24. Zhao S.H., Zhao F., Zheng J.Y., Gao L.F., Zhao X.J., Cui M.H. Radiol. Oncol. 2011, 45:196.
25. Cai L., Zhang G., Tong X., You Q., An Y., Wang Y., Guo L., Wang T., Zhu D., Zheng J. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010, 148:73.
26. Lee S.H., Mok H., Lee Y., Park T.G. J. Controlled Release 2011, 152:152.
27. Benfer M., Kissel T. Eur. J. Pharm. Biopharm. 2012, 80:247.
28. Lee S.H., Kim S.H., Park T.G. Biochem. Biophys. Res. Commun. 2007, 357:511.
29. de Assis C.F., Costa L.S., Melo-Silveira R.F., Oliveira R.M., Pagnoncelli M.G.B., Rocha H.A.O., de Macedo G.R., dos Santos E.S. World J. Microbiol. Biotechnol. 2012, 28:1097.
30. Kim E.K., Je J.Y., Lee S.J., Kim Y.S., Hwang J.W., Sung S.H., Moon S.H., Jeon B.T., Kim S.K., Jeon Y.J., Park P.J. Bioorg. Med. Chem. Lett. 2012, 22:6136.
31. Hu F.Q., Wu X.L., Du Y.Z., You J., Yuan H. Eur. J. Pharm. Biopharm. 2008, 69:117.
32. Ye Y.Q., Hu F.Q., Yuan H. Yao Xue Xue Bao 2004, 39:467.
33. Yang X.Z., Dou S., Sun T.M., Mao C.Q., Wang H.X., Wang J. J. Controlled Release 2011, 156:203.
34. Caldorera-Moore M., Guimard N., Shi L., Roy K. Expert Opin. Drug Deliv. 2010, 7:479.
35. Alshamsan A., Hamdy S., Samuel J., Kadi A.O.S.E., Lavasanifar A., Uludag H. Biomaterials 2010, 31:1420.
36. Das J., Das S., Paul A., Samadder A., Bhattacharyya S.S., Bukhsh A.R.K. Toxicol. Lett. 2014, 225:454.